Swiss National Bank Trims Holdings in Azenta, Inc. (NASDAQ:AZTA)

Swiss National Bank reduced its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 9.8% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,600 shares of the company's stock after selling 9,400 shares during the quarter. Swiss National Bank owned approximately 0.19% of Azenta worth $4,330,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. State of Alaska Department of Revenue boosted its holdings in Azenta by 355.2% in the fourth quarter. State of Alaska Department of Revenue now owns 25,899 shares of the company's stock valued at $1,294,000 after purchasing an additional 20,210 shares during the period. Stephens Inc. AR purchased a new position in shares of Azenta in the 4th quarter valued at about $313,000. SG Americas Securities LLC purchased a new position in shares of Azenta in the 4th quarter valued at about $813,000. Conestoga Capital Advisors LLC grew its position in shares of Azenta by 65.0% during the fourth quarter. Conestoga Capital Advisors LLC now owns 1,577,881 shares of the company's stock worth $78,894,000 after buying an additional 621,830 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its stake in shares of Azenta by 1.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,317,385 shares of the company's stock worth $65,922,000 after buying an additional 18,529 shares during the period. 99.08% of the stock is currently owned by hedge funds and other institutional investors.

Azenta Stock Performance

AZTA stock traded down $0.91 during midday trading on Friday, reaching $34.61. 687,601 shares of the company were exchanged, compared to its average volume of 608,108. The company has a market cap of $1.58 billion, a price-to-earnings ratio of -11.61 and a beta of 1.52. Azenta, Inc. has a 1-year low of $33.37 and a 1-year high of $63.58. The stock's 50-day simple moving average is $45.11 and its 200 day simple moving average is $46.27.

Remove Ads

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, topping the consensus estimate of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. On average, research analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts recently issued reports on AZTA shares. TD Cowen upgraded shares of Azenta to a "hold" rating in a research note on Thursday, February 27th. Stephens reaffirmed an "overweight" rating and set a $60.00 price objective on shares of Azenta in a research report on Thursday, January 2nd. Needham & Company LLC boosted their target price on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research note on Thursday, February 6th. Finally, Evercore ISI raised their price target on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a research note on Thursday, February 6th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, Azenta presently has an average rating of "Hold" and a consensus target price of $58.75.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.